Additionally, inhibition of the p53 pathway and activation of the MYC pathway by legumain secreted from glioblastoma cells lead to the malignant transformation of normal astrocytes, which enhances the invasive ability of glioblastoma cells [110]. Here, MYC is linked to glioblastoma.